Pulmonary alveolar proteinosis - a rare pulmonary toxicity of sirolimus

被引:19
作者
Pedroso, Sofia L. [1 ]
Martins, La Salete
Sousa, Sonia
Reis, Abilio
Dias, Leonidio
Henriques, Antonio C.
Sarmento, Antonio M.
Cabrita, Antonio
机构
[1] Hosp Geral Santo, Dept Nephrol, P-4040011 Oporto, Portugal
[2] Hosp Geral Santo Antonio, Dept Transplant, Oporto, Portugal
[3] Hosp Geral Santo Antonio, Dept Internal Med, Oporto, Portugal
关键词
immunosuppression; kidney transplant; pulmonary alveolar proteinosis; rapamycin; sirolimus;
D O I
10.1111/j.1432-2277.2006.00408.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
The aim of our paper is to describe an unusual pulmonary toxicity of sirolimus (SRL) in a kidney transplant recipient. We present a 34-year-old woman with a second renal transplantation, complicated with steroid-resistant acute rejection and chronic allograft dysfunction. Two years after initiating SRL, she presented complaints of progressive dyspnoea, nonproductive cough, chest pain and low-grade fever of 1 month duration. She had chronic allograft nephropathy and slight elevation of lactic dehydrogenase levels. After exclusion of common reasons of this condition, a computed tomography (CT) of the thorax and bronchoscopy was performed, revealing ground-glass opacification with polygonal shapes on CT and an opaque appearance with numerous macrophages on bronchoalveolar lavage. The alveolar macrophages stained positive by Periodic acid-Schiff. Diagnosis of pulmonary alveolar proteinosis (PAP) was made and drug-induced toxicity was suspected. SRL was withdrawn with marked improvement in the patients' clinical and radiological status. PAP resolved within 3 months without further therapy. PAP is a very rare complication of SRL therapy with only a few cases described. Withdrawal of SRL with conversion to another immunosuppressant seems to be an appropriate procedure in this condition.
引用
收藏
页码:291 / 296
页数:6
相关论文
共 18 条
[1]   Brief communication:: Sirolimus-associated pneumonitis:: 24 cases in renal transplant recipients [J].
Champion, L ;
Stern, M ;
Israël-Biet, D ;
Mamzer-Bruneel, MF ;
Peraldi, MN ;
Kreis, H ;
Porcher, R ;
Morelon, E .
ANNALS OF INTERNAL MEDICINE, 2006, 144 (07) :505-509
[2]   Sirolimus-induced pneumonitis presenting as acute respiratory distress syndrome [J].
Chau, Elaine M. C. ;
Chow, Wing-Hing .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (07) :867-868
[3]   Clinical application of sirolimus in renal transplantation: an update [J].
Chueh, SCJ ;
Kahan, BD .
TRANSPLANT INTERNATIONAL, 2005, 18 (03) :261-277
[4]   SECONDARY ALVEOLAR PROTEINOSIS IS A REVERSIBLE CAUSE OF RESPIRATORY-FAILURE IN LEUKEMIC PATIENTS [J].
CORDONNIER, C ;
FLEURYFEITH, J ;
ESCUDIER, E ;
ATASSI, K ;
BERNAUDIN, JF .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :788-794
[5]   Immunosuppressive strategies in transplantation [J].
Denton, MD ;
Magee, CC ;
Sayegh, MH .
LANCET, 1999, 353 (9158) :1083-1091
[6]   Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients [J].
Garrean, S ;
Massad, MG ;
Tshibaka, M ;
Hanhan, Z ;
Caines, AE ;
Benedetti, E .
CLINICAL TRANSPLANTATION, 2005, 19 (05) :698-703
[7]   Sirolimus (rapamycin)-based therapy in human renal transplantation -: Similar efficacy and different toxicity compared with cyclosporine [J].
Groth, CG ;
Bäckman, L ;
Morales, JM ;
Calne, R ;
Kreis, H ;
Lang, P ;
Touraine, JL ;
Claesson, K ;
Campistol, JM ;
Durand, D ;
Wramner, L ;
Brattström, C ;
Charpentier, B .
TRANSPLANTATION, 1999, 67 (07) :1036-1042
[8]   Reversible sirolimus-associated pneumonitis after heart transplantation [J].
Hamour, IM ;
Mittal, TK ;
Bell, AD ;
Banner, NR .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02) :241-244
[9]   Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: A phase II trial [J].
Kahan, BD ;
Julian, BA ;
Pescovitz, MD ;
Vanrenterghem, Y ;
Neylan, J .
TRANSPLANTATION, 1999, 68 (10) :1526-1532
[10]   Interstitial pneumonitis associated with sirolimus (rapamycin) therapy after liver transplantation [J].
Lennon, A ;
Finan, K ;
Fitzgerald, MX ;
McCormick, PA .
TRANSPLANTATION, 2001, 72 (06) :1166-1167